Jin Zhu

3.6k total citations
132 papers, 2.9k citations indexed

About

Jin Zhu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Jin Zhu has authored 132 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 39 papers in Oncology and 28 papers in Immunology. Recurrent topics in Jin Zhu's work include Monoclonal and Polyclonal Antibodies Research (15 papers), Glycosylation and Glycoproteins Research (12 papers) and HER2/EGFR in Cancer Research (9 papers). Jin Zhu is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (15 papers), Glycosylation and Glycoproteins Research (12 papers) and HER2/EGFR in Cancer Research (9 papers). Jin Zhu collaborates with scholars based in China, United States and Switzerland. Jin Zhu's co-authors include Qi Tang, Yuan Mao, Zhenqing Feng, Xiaojun Tang, Shou‐Nian Ding, Jianfei Huang, Dawei Zhang, Changjun Wang, Wei Zhao and Lin Xiong and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jin Zhu

127 papers receiving 2.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jin Zhu 1.3k 1.0k 532 394 341 132 2.9k
Kazuhiro Yoshikawa 1.0k 0.8× 660 0.6× 502 0.9× 455 1.2× 304 0.9× 159 2.5k
Subodh M. Lele 1.8k 1.4× 1.1k 1.1× 460 0.9× 652 1.7× 623 1.8× 128 4.2k
Laura Conti 961 0.8× 723 0.7× 901 1.7× 237 0.6× 396 1.2× 88 2.5k
Marc Mareel 1.7k 1.3× 1.4k 1.4× 460 0.9× 574 1.5× 761 2.2× 47 3.9k
Benjamin Swanson 2.0k 1.5× 1.6k 1.5× 1.0k 1.9× 404 1.0× 433 1.3× 62 3.8k
Andrea Petretto 1.5k 1.2× 675 0.7× 1.1k 2.1× 339 0.9× 351 1.0× 136 3.6k
Martin Falk 2.1k 1.6× 921 0.9× 525 1.0× 618 1.6× 280 0.8× 119 3.8k
Christine Unger 1.6k 1.2× 1.1k 1.1× 450 0.8× 237 0.6× 492 1.4× 34 3.3k
Christopher R. Shea 1.3k 1.0× 1.6k 1.6× 499 0.9× 599 1.5× 332 1.0× 157 4.4k
Jianfeng Chen 1.4k 1.1× 436 0.4× 711 1.3× 259 0.7× 396 1.2× 105 3.2k

Countries citing papers authored by Jin Zhu

Since Specialization
Citations

This map shows the geographic impact of Jin Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin Zhu more than expected).

Fields of papers citing papers by Jin Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin Zhu. The network helps show where Jin Zhu may publish in the future.

Co-authorship network of co-authors of Jin Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Jin Zhu. A scholar is included among the top collaborators of Jin Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin Zhu. Jin Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ravikumar, Sharada, et al.. (2024). Severe invasive infections linked to IRAK2 immune variants. International Journal of Infectious Diseases. 148. 107245–107245.
2.
Tao, Yiran, Yu Zhang, Yumeng Li, et al.. (2024). Computer-aided designing of a novel multi‑epitope DNA vaccine against severe fever with thrombocytopenia syndrome virus. BMC Infectious Diseases. 24(1). 476–476. 3 indexed citations
4.
Jin, Ke, Yang Zhan, Tingting Zhou, et al.. (2023). TRIM3 attenuates cytokine storm caused by Dabie bandavirus via promoting Toll-like receptor 3 degradation. Frontiers in Microbiology. 14. 1209870–1209870. 4 indexed citations
5.
Hu, Nannan, Jin Zhu, Yaping Han, et al.. (2023). The dose–response relationship between smoking and the risk factor for invasive pulmonary aspergillosis in patients with severe fever with thrombocytopenia syndrome. Frontiers in Microbiology. 14. 1209705–1209705. 7 indexed citations
6.
Jia, Lizhou, Tingting Yang, Xiaochen Huang, et al.. (2020). Trop2 Promotes Multidrug Resistance by Regulating Notch1 Signaling Pathway in Gastric Cancer Cells. Medical Science Monitor. 26. e919566–e919566. 11 indexed citations
7.
Zhou, Yan, Hongmei Yong, Xudong Wang, et al.. (2019). Elevated epiregulin expression predicts poor prognosis in gastric cancer. Pathology - Research and Practice. 215(5). 873–879. 16 indexed citations
8.
Mao, Yuan, Li Xu, Jun Wang, et al.. (2019). ROR1 associates unfavorable prognosis and promotes lymphoma growth in DLBCL by affecting PI3K/Akt/mTOR signaling pathway. BioFactors. 45(3). 416–426. 27 indexed citations
9.
10.
Jia, Lizhou, Tingting Yang, Xuan Gu, et al.. (2018). Translation elongation factor eEF1Bα is identified as a novel prognostic marker of gastric cancer. International Journal of Biological Macromolecules. 126. 345–351. 7 indexed citations
11.
Zhao, Wei, Guipeng Ding, Jinbo Wen, et al.. (2017). Correlation between Trop2 and amphiregulin coexpression and overall survival in gastric cancer. Cancer Medicine. 6(5). 994–1001. 17 indexed citations
12.
Blumenschein, George R., Jason C. Chandler, Edward B. Garon, et al.. (2016). PS01.59: CheckMate 370: A Master Protocol of Phase 1/2 Studies of Nivolumab as Maintenance or First-Line ± Standard-of-Care Therapies in Advanced NSCLC. Journal of Thoracic Oncology. 11(11). S307–S307. 4 indexed citations
13.
Hu, Jing, et al.. (2015). KRT6 interacting with notch1 contributes to progression of renal cell carcinoma, and aliskiren inhibits renal carcinoma cell lines proliferation in vitro.. PubMed Central. 8(8). 9182–8. 20 indexed citations
14.
Huang, Rong, et al.. (2015). Trastuzumab-cisplatin conjugates for targeted delivery of cisplatin to HER2-overexpressing cancer cells. Biomedicine & Pharmacotherapy. 72. 17–23. 21 indexed citations
15.
Sokolove, Jeremy, Michael Schiff, Roy Fleischmann, et al.. (2015). Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial. Annals of the Rheumatic Diseases. 75(4). 709–714. 135 indexed citations
16.
17.
Mao, Yuan, Mei Lü, Hong Lin, et al.. (2013). Prognostic Significance of EBV Latent Membrane Protein 1 Expression in Lymphomas: Evidence from 15 Studies. PLoS ONE. 8(4). e60313–e60313. 9 indexed citations
18.
Li, Hong, Chunyan Gu, Yang Dai, et al.. (2011). The efficacy of NP11-4-derived immunotoxin scFv-artesunate in reducing hepatic fibrosis induced by Schistosoma japonicum in mice. Journal of Biomedical Research. 25(2). 148–154. 7 indexed citations
19.
Ding, Guipeng, Ximin Chen, Jin Zhu, & Brian Cao. (2010). Identification of two aberrant transcripts derived from a hybridoma with amplification of functional immunoglobulin variable genes. Cellular and Molecular Immunology. 7(5). 349–354. 16 indexed citations
20.
Sun, Bo, Shuo Geng, Xiaojia Huang, et al.. (2010). Coleusin factor exerts cytotoxic activity by inducing G0/G1 cell cycle arrest and apoptosis in human gastric cancer BGC-823 cells. Cancer Letters. 301(1). 95–105. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026